Renalytix plc American Depositary Shares
RNLX
RNLX was delisted on the 7th of October, 2024.
21 hedge funds and large institutions have $6.37M invested in Renalytix plc American Depositary Shares in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 10 closing their positions.
13% more capital invested
Capital invested by funds: $5.65M → $6.37M (+$719K)
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
22% less funds holding
Funds holding: 27 → 21 (-6)
50% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 10
53% less call options, than puts
Call options by funds: $15K | Put options by funds: $32K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Pinnacle Associates
New York
|
+$190K |
| 2 |
NSIM
North Star Investment Management
Chicago,
Illinois
|
+$12.5K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$10.1K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$4K |
| 5 |
GG
Gofen & Glossberg
Chicago,
Illinois
|
+$1.56K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAM
Fred Alger Management
New York
|
-$394K |
| 2 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
-$368K |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$276K |
| 4 |
SPC
Slate Path Capital
New York
|
-$224K |
| 5 |
Lazard Asset Management
New York
|
-$191K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Citadel Advisors
Miami,
Florida
| – | -$100K | -64,069 | Closed |
|
27
Two Sigma Investments
New York
| – | -$44K | -34,540 | Closed |
|
28
Envestnet Asset Management
Chicago,
Illinois
| – | -$22K | -17,288 | Closed |
|
|
PAG
29
Private Advisor Group
Morristown,
New Jersey
| – | -$18K | -14,077 | Closed |
|
30
Two Sigma Advisers
New York
| – | -$16K | -12,300 | Closed |
|
RNLX Hedge Fund Activity: Q4 2022 in Review
21 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Renalytix plc American Depositary Shares (RNLX) for Q4 2022, worth a combined $6.37M — up 13% from $5.65M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of RNLX and 5 opened new positions — a net loss of 5 holders — while 7 trimmed existing stakes and 6 added.
The largest buyer was Pinnacle Associates, adding an estimated $190K. The largest seller was Fred Alger Management, exiting entirely with an estimated $394K sold.
- 21 institutional investors held Renalytix plc American Depositary Shares (RNLX) as of Q4 2022, down from 27 in Q3 2022.
- Funds reported $6.37M of Renalytix plc American Depositary Shares stock for Q4 2022, up 13% quarter-over-quarter.
- 5 funds opened new Renalytix plc American Depositary Shares positions in Q4 2022 and 10 closed out, a net change of -5 holders.
- The largest Renalytix plc American Depositary Shares buyer in Q4 2022 was Pinnacle Associates, an estimated $190K added.
- The largest Renalytix plc American Depositary Shares seller in Q4 2022 was Fred Alger Management, an estimated $394K sold.
Based on aggregated 13F filings for Q4 2022.